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IL4-10 SYNERKINE TO INDUCE DIRECT AND INDIRECT STRUCTURAL
CARTILAGE REPAIR IN OSTEOARTHRITIS
M.F. Pustjens, C. Steen-Louws, C.E. Hack, J.A. Van Roon,
S.C. Mastbergen, F.P. Lafeber. Univ. Med. Ctr. Utrecht, Utrecht, Netherlands
Purpose: Progressive articular cartilage degradation is central to
osteoarthritis (OA), and is driven by mechanisms of cartilage matrix
catabolic effects and anti-anabolic effects of chondrocytes. However, OA
is a disease mediated by and affecting the entire synovial joint organ.
Chronic, low-grade synovial inﬂammation contributes to symptoms
and disease progression. We recently developed IL4-10 synerkine, a
fusion protein composed of IL-4 and IL-10. It is demonstrated that these
cytokines inhibit production of pro-inﬂammatory cytokines such as IL-
1b, IL-6 and TNFa (Fiorentino, 1991; Hart, 1995; Lee, 2002), all impor-
tant in the degeneration of cartilage and inﬂammation of synovium in
osteoarthritis (Liu-Bryan and Terkeltaub, 2014). In human and animal in
vivo and in vitro experimental models the individual cytokines and IL-4
and IL-10 combined are shown to be effective. However, clinically
effects are modest, most likely due to limited bio-availability and
insufﬁcient immunosuppression. IL4-10 synerkine might overcome
these limitations and may successfully achieve structural repair in
diseases like OA because of synergistic effects of the cytokines. The
purpose of this study is to evuate the cartilage protective and anti-
inﬂammatroy effects of IL4-10 synerkine ex vivo.
Methods: Cartilage from the condyles of seven end-stage knee OA
patients selected for total knee replacement, was cultured for 4 days in
presence or absence of IL-4 (10ng/ml), IL-10 (10ng/ml), a combination of
IL-4 (10ng/ml) and IL-10 (10ng/ml), or IL4-10 synerkine (20ng/ml).
Changes in proteoglycan (PG) synthesis and PG release were studied.
Synovial tissue from six OA donors selected for total knee replacement
was cultured for 3 days under similar circumstances. Cytokine levels in
culture medium supernatants of both cartilage and synovium cultures
were measured by ELISA for IL-6, IL-8 and TNFa.
Results: Culturing OA cartilage in presence of IL4-10 synerkine
increased proteoglycan (PG) synthesis with 47.6% (p¼0.018), þ26.6% for
IL-4 alone,þ31.2% for IL-10 alone, orþ6.9% for IL-4 and IL-10 combined.
Only a small reduction of -8.7% (p¼0.018) in PG release was found for
the IL4-10 synerkine (-4.9% for IL-4 alone, -8.6% for IL-10 alone, or -6.7%
for IL-4 and IL-10 combined). The overall improved proteoglycan
turnover was in cocurrence with a signiﬁcant inhibition of Il-6, IL-8 and
TNF-a cytokine production by the cartilage in presence of the IL4-10
synerkine (IL-6 -81.9%, IL-8 -65.9% and -2.0% TNF-a, resp.). Moreover,
IL4-10 synerkine also reduced the production of IL-6, IL-8 and TNFa in
osteoarthritic synovium (-83.5%, -85.6% and -25.9% resp., all p<0.01).Conclusions: These data show that IL4-10 synerkine might induce both
structural repair and reduce inﬂammation in OA. Ex vivo, IL4-10 syn-
erkine has a direct effect on OA cartilage by affecting its proteoglycan
turnover and cytokine production. Inhibiting the synovial cytokine pro-
duction, adds indirectly to this structural repair of the cartilage. Together
with the pain inhibiting effects found in animal models of OA, these data
suggest disease modifying characteristics of the IL4-10 synerkine.
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KARTOGENIN LOADED PHOTO-CROSSLINKABLE SCAFFOLD FOR
CARTILAGE REGENERATION
D. Shi, x. Xu, Q. Jiang. Sports Med. and Adult Reconstruction, Nanjing,
China
Purpose: Hyaline cartilage injury, a common disease is seriously
affected the life quality of the patient and difﬁcult to be cured. Recently,
various kinds of methods have been conducted to solve this problem.
Scaffold-based cartilage tissue engineering is a promising one. Although
positive results were reported in many in vivo cartilage repair studies
with cartilage tissue engineering, adverse effects were also detected
because of using growth factors or exogenous cells. In this study, we
used a small molecule Kartogenin (KGN) loaded photo-crosslinkable
scaffold to restore cartilage defects through a cell homing way.
Methods: Small molecule KGN was synthesized and its chondrogenic
ability was tested on human synovium derived mesenchymal stem cells
(SMSCs). PLGA nanoparticles loaded with KGN were prepared by a
single oil-in-water (O/W) emulsion/solvent evaporation method. Hya-
luronic acid (HA) was modiﬁed with double bond by reacting with the
methacrylic anhydride (MA). The HA hydrogel encapsulating KGN loa-
ded PLGA nanoparticles (HA/KGN-NPs) can be formed by UV irradiation
for 30 s, and in vitro drug released study was studied. Full-thickness
cartilage defects were created in New Zealand White animals and the
HA/KGN-NPs were used to repair them in vivo. The animals were sac-
riﬁced at 4 and 12 weeks after operation. Histology and immunohis-
tochemistry were used to evaluate the repair quality.
Results: KGN had the ability to induce human SMSCs into chondrocytes
in vitro. The sustained release of KGN from PLGA nanoparticles and
hyaluronic acid hydrogel encapsulating PLGA nanoparticles at 37 oC
was found. After HA/KGN-NPs hydrogel was formed in cartilage defects
for 4 and 12 weeks, toluidine blue staining, safranin O staining and
immunohistology staining for type I and type II collagen all showed
signiﬁcantly better restoration.
Conclusions: This ultraviolet-reactive, rapidly cross-linkable scaffold
with KGN releasing is a great therapoutic candidate for cartilage defects.
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POLYELECTROLYTE MICROENCAPSULES LOADED WITH C-TYPE
NATRIURETIC PEPTIDE PROTECT CARTILAGE FROM IL-1B INDUCED
DAMAGE
N. Peake y, A. Pavlov y, A. D'Souza y, I. Alfasahin z, B. Pingaan-Murphy z,
G. Sukhurukov y, A. Hobbs y, T. Chowdhury y. yQueen Mary, Univ. of
London, London, United Kingdom; zUniv. of Malaya, Kuala Lumpur,
Malaysia
Purpose: CNP exhibits potent anti-inﬂammatory and pro-anabolic
effects in chondrocytes. For example, the peptide blocked production of
nitric oxide (NO) and restored matrix synthesis in human chondrocytes
cultured with IL-1b. These anti-inﬂammatory effects indicate that CNP
has the potential to repair cartilage damage observed in osteoarthritis
(OA). However, there is a lack of effective treatments for OA due to poor
targeting of therapeutics into the articular joint, and agents that have a
short half-life. Recently, layer-by-layer preparation of microcapsules has
been developed as a depot system for the stable encapsulation and
sustained delivery of bioactive agents. The present study fabricated
multilayer polyelectrolyte microcapsules loaded with CNP, and exam-
ined whether this approach could have protective effects in cartilage
explants treated with IL-1b.
Methods: Microcapsules were prepared using layer-by-layer assembly
of a TRITC-labelled polyelectrolyte shell around a sacriﬁcial calcium
carbonate template loaded with 100mM FITC-conjugated CNP. Incor-
poration of labelled CNP was conﬁrmed by ﬂuorescence microscopy.
Encapsulation efﬁciency and CNP release were determined by ﬂuo-
rescence assay in supernatents taken during preparation and after
encapsulation, respectively. Microcapsule characteristics (morphology,
